{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Tezacaftor  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Tezacaftor. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Tezacaftor  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "tezacaftor",
    "trial_2_text": "Tezacaftor  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Tezacaftor Supplement: 60 participants will take Tezacaftor 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Tezacaftor. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Tezacaftor  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "78": 0.23088297247886658,
      "189": 0.22087964415550232,
      "188": 0.2198229730129242,
      "87": 0.20078535377979279,
      "173": 0.1575084775686264,
      "123": 0.14511248469352722,
      "243": 0.13870136439800262,
      "20": 0.13862323760986328,
      "37": 0.13454580307006836,
      "177": 0.12958988547325134,
      "77": 0.12385907024145126,
      "200": 0.12350072711706161,
      "9": 0.11891669034957886,
      "21": 0.11105501651763916,
      "67": 0.10681411623954773,
      "350": 0.10259920358657837,
      "68": 0.10115718841552734,
      "14": 0.09779402613639832,
      "28": 0.09654105454683304,
      "64": 0.09547141939401627,
      "97": 0.08998923003673553,
      "49": 0.0893709734082222,
      "46": 0.08861695975065231,
      "17": 0.08832094073295593,
      "193": 0.08728986978530884,
      "61": 0.08637795597314835,
      "2": 0.08584269881248474,
      "228": 0.08543028682470322,
      "30": 0.08449778705835342,
      "5": 0.08129856735467911,
      "341": 0.07877951860427856,
      "261": 0.0786004438996315,
      "204": 0.07782566547393799,
      "131": 0.07652163505554199,
      "29": 0.07631517946720123,
      "79": 0.07602398097515106,
      "76": 0.07526177912950516,
      "508": 0.07326006889343262,
      "116": 0.07234245538711548,
      "151": 0.07159731537103653,
      "69": 0.07041627168655396,
      "147": 0.07037971913814545,
      "239": 0.07002982497215271,
      "126": 0.07001607120037079,
      "454": 0.0686604380607605,
      "82": 0.06694387644529343,
      "114": 0.06688632816076279,
      "36": 0.06659680604934692,
      "422": 0.06619541347026825,
      "38": 0.06578803062438965,
      "179": 0.06512336432933807,
      "747": 0.06461936980485916,
      "139": 0.06438268721103668,
      "85": 0.06407660245895386,
      "441": 0.06322919577360153,
      "194": 0.06283202767372131,
      "186": 0.062397297471761703,
      "104": 0.06198417395353317,
      "86": 0.06133396551012993,
      "276": 0.06008962541818619,
      "396": 0.05931413918733597,
      "101": 0.0582975372672081,
      "102": 0.05723316967487335,
      "286": 0.05699601769447327,
      "466": 0.056487973779439926,
      "92": 0.05626055598258972,
      "132": 0.05582465976476669,
      "138": 0.055700141936540604,
      "18": 0.052578143775463104,
      "27": 0.05134247615933418,
      "35": 0.05068095028400421,
      "118": 0.05034393072128296,
      "191": 0.0502137690782547,
      "84": 0.049616627395153046,
      "33": 0.049388594925403595,
      "105": 0.04928826540708542,
      "122": 0.04876372218132019,
      "297": 0.04820539802312851,
      "535": 0.04800168424844742,
      "163": 0.04763782024383545,
      "355": 0.047250896692276,
      "363": 0.047117188572883606,
      "164": 0.04703148826956749,
      "72": 0.04663337767124176,
      "269": 0.04641736298799515,
      "456": 0.0461154580116272,
      "98": 0.04493813216686249,
      "356": 0.04484662413597107,
      "282": 0.044649526476860046,
      "166": 0.04437093809247017,
      "180": 0.04362000152468681,
      "342": 0.043583713471889496,
      "262": 0.04350198432803154,
      "522": 0.04320570081472397,
      "11": 0.04286804422736168,
      "234": 0.04279525205492973,
      "371": 0.04255171865224838,
      "153": 0.042473793029785156,
      "130": 0.042022962123155594,
      "94": 0.04139801859855652
    },
    "trial_2_ae": {
      "78": 0.23088297247886658,
      "189": 0.22087964415550232,
      "188": 0.2198229730129242,
      "87": 0.20078535377979279,
      "173": 0.1575084775686264,
      "123": 0.14511248469352722,
      "243": 0.13870136439800262,
      "20": 0.13862323760986328,
      "37": 0.13454580307006836,
      "177": 0.12958988547325134,
      "77": 0.12385907024145126,
      "200": 0.12350072711706161,
      "9": 0.11891669034957886,
      "21": 0.11105501651763916,
      "67": 0.10681411623954773,
      "350": 0.10259920358657837,
      "68": 0.10115718841552734,
      "14": 0.09779402613639832,
      "28": 0.09654105454683304,
      "64": 0.09547141939401627,
      "97": 0.08998923003673553,
      "49": 0.0893709734082222,
      "46": 0.08861695975065231,
      "17": 0.08832094073295593,
      "193": 0.08728986978530884,
      "61": 0.08637795597314835,
      "2": 0.08584269881248474,
      "228": 0.08543028682470322,
      "30": 0.08449778705835342,
      "5": 0.08129856735467911,
      "341": 0.07877951860427856,
      "261": 0.0786004438996315,
      "204": 0.07782566547393799,
      "131": 0.07652163505554199,
      "29": 0.07631517946720123,
      "79": 0.07602398097515106,
      "76": 0.07526177912950516,
      "508": 0.07326006889343262,
      "116": 0.07234245538711548,
      "151": 0.07159731537103653,
      "69": 0.07041627168655396,
      "147": 0.07037971913814545,
      "239": 0.07002982497215271,
      "126": 0.07001607120037079,
      "454": 0.0686604380607605,
      "82": 0.06694387644529343,
      "114": 0.06688632816076279,
      "36": 0.06659680604934692,
      "422": 0.06619541347026825,
      "38": 0.06578803062438965,
      "179": 0.06512336432933807,
      "747": 0.06461936980485916,
      "139": 0.06438268721103668,
      "85": 0.06407660245895386,
      "441": 0.06322919577360153,
      "194": 0.06283202767372131,
      "186": 0.062397297471761703,
      "104": 0.06198417395353317,
      "86": 0.06133396551012993,
      "276": 0.06008962541818619,
      "396": 0.05931413918733597,
      "101": 0.0582975372672081,
      "102": 0.05723316967487335,
      "286": 0.05699601769447327,
      "466": 0.056487973779439926,
      "92": 0.05626055598258972,
      "132": 0.05582465976476669,
      "138": 0.055700141936540604,
      "18": 0.052578143775463104,
      "27": 0.05134247615933418,
      "35": 0.05068095028400421,
      "118": 0.05034393072128296,
      "191": 0.0502137690782547,
      "84": 0.049616627395153046,
      "33": 0.049388594925403595,
      "105": 0.04928826540708542,
      "122": 0.04876372218132019,
      "297": 0.04820539802312851,
      "535": 0.04800168424844742,
      "163": 0.04763782024383545,
      "355": 0.047250896692276,
      "363": 0.047117188572883606,
      "164": 0.04703148826956749,
      "72": 0.04663337767124176,
      "269": 0.04641736298799515,
      "456": 0.0461154580116272,
      "98": 0.04493813216686249,
      "356": 0.04484662413597107,
      "282": 0.044649526476860046,
      "166": 0.04437093809247017,
      "180": 0.04362000152468681,
      "342": 0.043583713471889496,
      "262": 0.04350198432803154,
      "522": 0.04320570081472397,
      "11": 0.04286804422736168,
      "234": 0.04279525205492973,
      "371": 0.04255171865224838,
      "153": 0.042473793029785156,
      "130": 0.042022962123155594,
      "94": 0.04139801859855652
    }
  },
  "safety": {
    "trial_1_safety": 0.23695336282253265,
    "trial_2_safety": 0.23695336282253265
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.48090794682502747
  }
}